| Literature DB >> 7648397 |
E Maggi1, F Annunziato, R Manetti, R Biagiotti, M G Giudizi, A Ravina, F Almerigogna, N Boiani, M Alderson, S Romagnani.
Abstract
CD30 is a member of the tumor necrosis factor receptor superfamily, preferentially expressed by T cells producing type 2 helper (Th2) cytokines, whose ligand (CD30L) has been identified on B cells, activated macrophages, and a subset of activated T cells. We show here that cross-linking CD30 with an agonistic CD30-specific monoclonal antibody, as well as with CD30L+ CD8+ T cell clones or CD30L+ B cells, enhanced HIV replication in CD4+ T cells from HIV-infected individuals, and such a potentiating effect was inhibited by anti-CD30L antibody. The anti-CD30L antibody also exerted a suppressive effect on spontaneous HIV replication occurring in lymph node cells from an HIV-sero-positive patient, showing CD30L expression by both B and CD8+ T lymphocytes. Thus, CD30 triggering by CD30L-expressing cells may plan an important role in the activation of HIV expression from latently infected CD4+ T cells.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7648397 DOI: 10.1016/1074-7613(95)90094-2
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745